4th Quarter - Report — LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION (2012)

Firm

LIFE TECHNOLOGIES CORPORATION

Client

LIFE TECHNOLOGIES CORPORATION

Income

—

Expenses

$150,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

New and Reconsidered Clinical Laboratory Fee Schedule (CLFS) Test Codes and Preliminary Payment Determinations; Provisions regarding coding for certain diagnostics.

Lobbyist	Covered position, as disclosed
AMY MUHLBERG	N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Homeland Security HOM

H.R. 5855: Department of Homeland Security Appropriations Act of 2013; Provisions regarding DNA testing requirements.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5855 (112th)

S. 1599, Sequestration/implementation of the Budget Control Act of 2011: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Sequestration/Provisions regarding National Institutes of Health funding. FY 2013 Agriculture Appropriations: Provisions regarding FDA appropriations.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 1599 (112th)

Medical/Disease Research/Clinical Labs MED

Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A
AMY MUHLBERG	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3207 (112th)

Law Enforcement/Crime/Criminal Justice LAW

H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 3250 (112th), S. 250 (112th), H.R. 6628 (112th), S. 517 (112th), H.R. 6014 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.